Alexion Pharmaceuticals
Norvin D'cunha is a seasoned professional with extensive experience in IT portfolio performance, financial management, and operational excellence, currently serving as Director at Alexion Pharmaceuticals, Inc. since June 2014. Past roles include Director, Global Process Owner Procure to Pay, and Associate Director, Strategic Vendor Management, Intelligent Automation COE Lead. Prior to Alexion, Norvin held positions as Transition/Project Manager at Accenture and Transition Manager at Tata Consultancy Services. Education includes a Leadership and Change Management degree from the Indian Institute of Management Ahmedabad, an MBA in Finance from N.L.Dalmia Institute of Management Studies and Research, and several other qualifications in accountancy and software technology. Norvin holds certifications including PMP, SAFe, GRCP, and Lean Six Sigma.
This person is not in any teams
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.